Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
This study is currently recruiting participants.
Verified April 2013 by Van Andel Research Institute
Sponsor:
Giselle Sholler
Collaborators:
Van Andel Research Institute
Archer Biosciences, Inc.
Information provided by (Responsible Party):
Giselle Sholler, Van Andel Research Institute
ClinicalTrials.gov Identifier:
NCT01483820
First received: November 28, 2011
Last updated: April 5, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | November 2018 |
| Estimated Primary Completion Date: | November 2014 (Final data collection date for primary outcome measure) |